Amanta Healthcare Board Approves Revision of Chairman’s Remuneration
Amanta Healthcare Limited announced that its Board of Directors, at a meeting held on May 19, 2026, approved a revision in the remuneration package for its Chairman & Managing Director, Shri Bhavesh Girishbhai Patel. The revised compensation structure is subject to obtaining approval from the shareholders via a Special Resolution at the upcoming Annual General Meeting.Shri Bhavesh Girishbhai Patel, who serves as the Chairman & Managing Director, was the subject of the remuneration review. The Board determined the proposed changes, which will be effective from April 1, 2026, and remain in place until the company's next re-appointment.
The details of the proposed remuneration revision are as follows:
| Detail | Existing Remuneration | Revised Remuneration Proposed |
|---|---|---|
| Amount | 10,00,000 P.M. | 13,29,000 P.M. |
| Nature of Change | N/A | Revision in remuneration |
The Board approved this revision of remuneration, noting that while the financial details have been settled, the final approval rests with the shareholders through a Special Resolution.
AMANTA Stock Price Movement
Today, Amanta Healthcare Limited shares edged higher, gaining 4.91% and settling at ₹132.36. The move occurred amid a robust trading session, with the stock recording a total volume of 101,401 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.